Genetically diverse CC and DO mouse models enable comprehensive assessments of novel tuberculosis vaccines
Authors:
Open Access
- 5 June 2026
- journal article
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Abstract
Development of a new vaccine for tuberculosis (TB) to replace the BCG vaccine has been hampered by the lack of a preclinical vaccine model that accurately reflects the genetic heterogeneity of the human population. We previously tested both Collaborative Cross (CC) and Diversity Outbred (DO) mice, which collectively reflect the genetic diversity of an outbred population, as models for preclinical vaccine testing. Using both CC and DO mice, we compared the ability of two different strategies to enhance BCG-mediated protection against Mycobacterium tuberculosis (Mtb). BCG::ESX-1Mmar is genetically modified to express the esx-1 region of Mycobacterium marinum. In contrast, the BCG/ChAd:TB strategy relies on boosting BCG-induced immunity using a chimp adenoviral vectored vaccine expressing the mycobacterial antigens Ag85A, TB10.4, and RpfB administered by the intranasal route. Both BCG::ESX-1Mmar and BCG/ChAd:TB vaccination strategies significantly protect mouse strains that were not well protected by BCG. Although both vaccination strategies were associated with reduced bacterial growth in CC and DO mice, bacterial control did not correlate with survival. Both BCG::ESX-1Mmar and BCG/ChAd:TB induced immune signatures after Mtb challenge in the tested CC strains that were previously associated with protection in traditional inbred mouse strains. Our findings established the use of both CC and DO mice as robust platforms that incorporate host genetic diversity for the preclinical evaluation of TB vaccines.Keywords
Funding Information
- Agence Nationale pour la Recherche (ANR-10-LABX62-IBEID)
- TBVAC-HORIZON project (101080309)
- The Canadian Institutes for Health Research (CIHR) Foundation Program
- National Institute of Allergy and Infectious Diseases (5P01AI181898)
- National Institute of Allergy and Infectious Diseases (5P01AI181898)
This publication has 30 references indexed in Scilit:
- Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challengeVaccine, 2025
- Using the Collaborative Cross and Diversity Outbred Mice in ImmunologyCurrent Protocols, 2022
- Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB ProtectionCell Reports, 2017
- TuberculosisNature Reviews Disease Primers, 2016
- ESX secretion systems: mycobacterial evolution to counter host immunityNature Reviews Microbiology, 2016
- ESX/type VII secretion systems and their role in host–pathogen interactionCurrent Opinion in Microbiology, 2009
- The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosisVaccine, 2008
- Laboratory Maintenance of Mycobacterium tuberculosisCurrent Protocols in Microbiology, 2007
- Prime-boost immunisation strategies for tuberculosisMicrobes and Infection, 2005
- The Collaborative Cross, a community resource for the genetic analysis of complex traitsNature Genetics, 2004